Close mobile menu×
Close mobile menu

Pietro A. Canetta, MD

Board Certifications: 
Nephrology, Internal Medicine
Expertise in: 
Cancer Care
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-0320

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Nephrology
  • Internal Medicine

Clinical Expertise

  • Cancer Care
  • Glomerular Diseases and Nephrotic Syndrome
  • Glomerulonephritis
  • Lupus Nephritis
  • Vasculitis
  • Interstitial Nephritis
  • Polycystic Kidney Disease
  • Transplant Nephrology
  • Genetic Disorder
  • Chronic Kidney Disease
  • Hypertension
  • Biopsies
  • Clinical Research

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

  • Alpha Omega Alpha Medical Honor Society, 2004
  • Housestaff Teaching Award to a Senior Resident, 2008: In recognition of excellence in clinical teaching at NewYork-Presbyterian Hospital
  • Clinic Resident Award, 2008: In recognition of excellence in ambulatory medicine by a housestaff officer at Columbia University Medical Center, NewYork-Presbyterian Hospital
  • Critical Care Resident Award, 2008: In recognition of excellence in critical care medicine by a housestaff officer at Columbia University Medical Center, NewYork-Presbyterian Hospital
  • New York Society of Nephrology, First Prize abstract ("Clinical Science" category), Fellows Night, 2011

About Pietro Canetta

Academic Titles

  • Assistant Professor of Medicine at CUMC

Committee/Societies/Council Memberships

American Society of Nephrology

International Society of Nephrology

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Italian
  • Spanish

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Indemnity
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Access (Exchange)
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Indemnity
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO
  • The Empire Plan (NYSHIP)

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
Room 202
New York, New York 10032
Phone: (212) 305-0320
Fax:
(212) 342-1814
Primary

Research

Selected Publications

  • Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J.  Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Annals of Internal Medicine, 2008 Jun 3;148(11):810-819. PMID: 18519927
  • Dahl K, Canetta PA, D'Agati VD, Radhakrishnan J.  A 56-year-old woman with sarcoidosis and acute renal failure. Kidney International, 2008 Sep;74(6):817-821
  • Canetta PA, Bomback AS, Radhakrishnan J.  Treating Lupus in the kidney: Where are we now, and where are we going?  Discovery Medicine. 2011 Oct; 12(65):341-349. PMID: 22031671
  • Nickolas TL, Schmitt-Ott K, Canetta PA, Forster C, Singer E, Sise M, Elger A, Maarouf O, Sola-Del Valle DA, O'Rourke M, Sherman E, Lee P, Geara A, Imus P, Guddati A, Polland A, Rahman W, Elitok S, Malik N, Giglio J, El-Sayegh S, Devarajan P, Hebbar S, Saggi SJ, Hahn B, Kettritz R, Luft FC, and Barasch J.  Diagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron Damage: A Multicenter Prospective Cohort Study.  J Am Coll Cardiol, 2012 Jan 17; 59(3):246-255. PMID: 22240130
  • Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D’Agati VD, Canetta PA, Radhakrishnan J, and Appel GB. Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis. Clin J Am Soc Nephrol. May 2012; 7(5):748-756. PMID: 22403278
  • Bomback AS, Canetta PA, Beck Jr LH, Ayalon R, Radhakrishnan J, Appel GB. Treatment of Resistant Glomerular Diseases with Adrenocorticotropic Hormone Gel: A Prospective Trial. Am J Nephrol, 2012 Jun 19;36(1):58-67. PMID: 22722778
  • Bomback AS, Rekhtman Y, Klemmer PJ, Canetta PA, Radhakrishnan J, Appel GB, Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy, Journal of American Society of Hypertension. 2012 Sep-Oct;6(5):338-45.  PMID: 22995802
  • Morris H, Canetta PA, Appel GB. Impact of the ALMS and MAINTAIN Trials on the Management of Lupus Nephritis. Nephrology Dialysis Transplantation. 2013 Jun;28(6):1371-6. PMID: 23233523
  • Canetta PA, Radhakrishnan J.  Impact of the National Institutes of Health focal segmental glomerulosclerosis (NIH FSGS) clinical trial on the treatment of steroid-resistant FSGS. Nephrology Dialysis Transplantation. 2013 Mar;28(3):527-34. PMID: 23248028
  • Hogan J, Bomback AS, Mehta K, Canetta PA, Rao MK, Appel GB, Radhakrishnan J, Lafayette RA. Treatment of Idiopathic FSGS with Adrenocorticotropic Hormone Gel. Clin J Am Soc Nephrol. 2013 Dec;8(12):2072-81. PMID: 24009220
  • Canetta PA, Kiryluk K, Appel GB. Emerging Tests and Therapies for IgA Nephropathy. Clin J Am Soc Nephrol. 2014 Mar;9(3):617-625. PMID: 24071652
  • Patel K, Dillon JJ, Leung N, Bomback AS, Appel GB, D’Agati V, Canetta PA. Use of bortezomib in heavy-chain deposition disease: a report of three cases. Am J Kidney Dis. 2014 Jul;64(1):123-7. PMID: 24613055
  • Moeller S, Canetta PA, Arguelles C, Snyder H, Green PH, Kiryluk K, Alaedini A.  Lack of Serologic Evidence to Link IgA Nephropathy with Celiac Disease or Immune Reactivity to Gluten. PLOS ONE. 2014 Apr 14;9(4):e94677. PMID: 24732864
  • Hogan J, Restivo M, Canetta PA, Herlitz LC, Radhakrishnan J, Appel GB, Bomback AS.  Rituximab treatment for fibrillary glomerulonephritis. Nephrol Dial Transplant. 2014 Oct;29(10):1925-31. PMID: 24867652